美多巴单用及与多巴胺受体激动剂合用治疗帕金森病的临床疗效观察

来源 :中华神经科杂志 | 被引量 : 0次 | 上传用户:guanxming
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的 评定单用美多巴 (L dopa) ,L dopa与多巴胺受体激动剂 [溴麦角隐亭碱 (BM)或甲磺酸培高利特 (PM) ]合用治疗帕金森病的疗效和安全性。方法 采用多中心、开放式分组 ,单用L dopa组 4 7例 ,L dopa +BM组 4 3例和L dopa +PM组 4 8例。临床疗效采用改良Webster量表和帕金森病运动功能量表 (MDRSPD)进行治疗前后的评定。同时取血检测肝肾功能 ,血、尿常规 ,测量血压、脉搏和做心电图检查。单用L dopa组平均日用量 (5 2 3 3± 2 35 9)mg;L dopa +BM组平均日用量为L dopa(5 2 6 7± 2 4 1 3)mg ,BM(7 3± 1 5 )mg;L dopa +PM组平均日用量为L dopa(5 5 8 3± 192 9)mg,PM(0 2 35± 0 0 4 5 )mg。结果 Webster量表、MDRSPD量表的临床总有效率 ,单用L dopa组均为74 5 % ,L dopa +BM组分别为 6 9 8%和 79 1% ,L dopa +PM组分别为 77 9%和 81 3%。不良反应发生率单用L dopa组为 2 7 7% ,L dopa +BM组为 39 5 % ,L dopa+PM组为 18 8%。结论 单用L dopa ,L dopa+BM和L dopa +PM治疗帕金森病均有效 ,对于早期帕金森病可以选用单一L dopa治疗 ;对于晚期帕金森病 ,可以选用L dopa与多巴胺受体激动剂联合治疗 Objectives To evaluate the efficacy and safety of L dopa alone, L dopa in combination with dopamine receptor agonist [bromocriptine (BM) or pergolide mesylate] in the treatment of Parkinson’s disease . Methods A multicenter, open group was used. In the L dopa group alone, 47 patients were treated with L dopa + BM and 43 patients with L dopa + PM were treated with L dopa + PM. Clinical Efficacy Assessments before and after treatment with the modified Webster scale and the Parkinson’s Disease Motor Function Scale (MDRSPD). At the same time, blood test liver and kidney function, blood, urine, blood pressure, pulse and ECG check. The average daily dose of L dopa was (523 ± 2 359) mg, while that of L dopa + BM was L dopa (5267 ± 2 413 mg) and that of BM (73 ± 1 5) mg. L dopa (5583 ± 192 9) mg, PM (0 35 ± 0 0 45) mg daily. Results The total effective rate of Webster scale and MDRSPD scale were 74 5% in L dopa group alone, 69.8% and 79.1% in L dopa + BM group and 77 9 in L dopa + PM group respectively % And 81 3%. The incidence of adverse reactions was 27.7% for L dopa alone, 39.5% for L dopa + BM, and 18.8% for L dopa + PM. Conclusions The treatment of Parkinson’s disease with L dopa, L dopa + BM and L dopa + PM alone is effective. For patients with early Parkinson’s disease, single L dopa can be used. For advanced Parkinson’s disease, L dopa and dopamine receptor agonist Combination therapy
其他文献
新课程在选修4系列的《坐标系与参数方程》中介绍了有关坐标系伸缩变换的概念.  定义 设点P(x,y)是平面直角坐标系中的任意一点,在变换φ:x′=λx(λ>0)  y′=μy(μ>0)的作用下,点P(x,y)对应到点P′(x′,y′),则称φ为平面直角坐标系中的坐标伸缩变换.  在这种变换下,有  性质1 直线与曲线的位置关系保持不变;